SQZ BIOTECHNOLOGIES CO's ticker is SQZ and the CUSIP is 78472W104. A total of 5 filers reported holding SQZ BIOTECHNOLOGIES CO in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $283,577 | -51.9% | 1,050,286 | -0.1% | 0.01% | -60.0% |
| Q1 2023 | $588,992 | -25.5% | 1,051,771 | -1.5% | 0.02% | -21.1% |
| Q4 2022 | $790,435 | -67.5% | 1,068,155 | 0.0% | 0.02% | -65.5% |
| Q3 2022 | $2,435,000 | -28.3% | 1,068,155 | 0.0% | 0.06% | -34.5% |
| Q2 2022 | $3,397,000 | -33.2% | 1,068,155 | +1.1% | 0.08% | -5.6% |
| Q1 2022 | $5,083,000 | -46.1% | 1,056,786 | 0.0% | 0.09% | -16.8% |
| Q4 2021 | $9,437,000 | -38.1% | 1,056,786 | 0.0% | 0.11% | -30.5% |
| Q3 2021 | $15,239,000 | +7.3% | 1,056,786 | +7.5% | 0.15% | +15.8% |
| Q2 2021 | $14,206,000 | +8.2% | 983,096 | +2.4% | 0.13% | +9.9% |
| Q1 2021 | $13,131,000 | -51.6% | 959,832 | +2.5% | 0.12% | -72.1% |
| Q4 2020 | $27,124,000 | – | 935,971 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRIDGER MANAGEMENT, LLC | 807,827 | $23,411,000 | 1.79% |
| Alphabet Inc. | 831,389 | $24,094,000 | 1.16% |
| Artal Group S.A. | 1,606,308 | $46,551,000 | 1.00% |
| 683 Capital Management, LLC | 466,176 | $13,510,000 | 0.64% |
| MAVERICK CAPITAL LTD | 935,971 | $27,124,000 | 0.43% |
| Temasek Holdings (Private) Ltd | 2,513,924 | $72,854,000 | 0.31% |
| CAAS CAPITAL MANAGEMENT LP | 150,000 | $4,347,000 | 0.04% |
| HRT FINANCIAL LP | 17,456 | $505,000 | 0.01% |
| ETF MANAGERS GROUP, LLC | 11,660 | $350,000 | 0.01% |
| Hudock, Inc. | 350 | $10,000 | 0.00% |